Investors / Greece / Kos Biotechnology Partners
Kos Biotechnology Partners
Venture capital · Greece · Europe
Kos Biotechnology Partners is a Greece-based venture capital firm dedicated to life sciences. It partners with founders and global experts to build a regional life sciences ecosystem connecting Greek, European and US biotech.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechtherapeuticspharma servicestech bioartificial intelligence
Your fit with Kos Biotechnology Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsKos Biotechnology Partners lists 5 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its largest theme is Healthcare & Biotech (100%). 60% of its companies are based in United States. It invests most often alongside Andreessen Horowitz, BioGeneration Ventures and Bioqube Ventures.
Counts come from funding rounds that name Kos Biotechnology Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundThe rounds that name Kos Biotechnology Partners do not give a stage.
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 4th | 5 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 92th | 20% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Andreessen Horowitz | 1 |
| BioGeneration Ventures | 1 |
| Bioqube Ventures | 1 |
| Brandon BioCatalyst | 1 |
| Brandon Capital | 1 |
| Canaan | 1 |
| Chemistry | 1 |
| EcoR1 Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Andreessen Horowitz
Compare Kos Biotechnology Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Kos Biotechnology Partners| Date | Company | Stage |
|---|---|---|
| 2 Feb 2026 | Round Led |
Round details for Kos Biotechnology Partners
Amounts, full round histories and every co-investor in Kos Biotechnology Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
5 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| CatalYm is developing a safe and efficacious immune therapy for solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Epikast partners with biopharma and healthcare organizations to engage their stakeholders, including patients, physicians, and other healthcare providers, by providing medically trained talent and AI-driven engagement tools. | Healthcare & Biotech | Feb 2026Round | Page + round | |
| Portfolio page | ||||
| Golden Age Health is a commercial platform and partner for rare and specialty medicines, connecting advanced therapies with patients and sourcing assets for global development and commercialization. | Healthcare & Biotech | Portfolio page | ||
| Rezo integrates various scientific fields to create maps of molecular disease networks and identify targets for precision therapeutics | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- kosbp.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 2 Feb 2026
- Companies checked
- 5
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Kos Biotechnology Partners' profile as data
Pull Kos Biotechnology Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/kosbp.com
# also
GET /v1/firms/kosbp.com/portfolio
GET /v1/firms/kosbp.com/coinvestors
GET /v1/firms/kosbp.com/news